AzTrials
AzTrials

Condition

Pulmonary Embolism Clinical Trials

Studies of pulmonary embolism, matched by condition name and medical subject headings. Start with those open to enrolment.

840 registered studies

In numbers

Open to volunteers
148
Active
173
With results posted
101
All registered
840

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 148
  • Symptomatic Venous Thromboembolism (VTE)

    REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

    • Recruiting
    • Age: 18 years and older
    • Phase 3

    This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA).

    Trial name
    ROXI-ASPEN (NCT07213778)
    Testing
    REGN7508, Acetylsalicylic Acid (ASA)
    Where
    51 sites in United States, Greece and 3 more
    Volunteers
    2,000 people
    Sponsor
    Regeneron Pharmaceuticals
    Can I take part? ROXI-ASPEN
  • Arterial Thromboembolism, Venous Thromboembolism

    Aspiration Thrombectomy Using the Symphony or Prodigy System

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Medical device

    The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.

    Conditions
    Arterial Thromboembolism, Venous Thromboembolism, Pulmonary Embolism
    Trial name
    CLEAR-IT (NCT07350499)
    Testing
    Prodigy Thrombectomy System, Symphony Thrombectomy System
    Where
    13 sites in United States
    Volunteers
    750 people
    Sponsor
    Imperative Care, Inc.
    Can I take part? CLEAR-IT
  • Venous Thromboembolism (VTE)

    Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

    • Recruiting
    • Age: 18 years and older
    • Phase 3

    This study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2.

    Trial name
    ROXI-CAT-II (NCT07493304)
    Testing
    REGN7508, Apixaban
    Where
    13 sites in United States, Bulgaria and 3 more
    Volunteers
    1,600 people
    Sponsor
    Regeneron Pharmaceuticals
    Can I take part? ROXI-CAT-II
  • Pulmonary Embolism Acute

    Post Pulmonary Embolism In Patients Treated With Catheter Based Therapy

    • Not yet recruiting
    • Age: 18 to 80 years
    • Pill or oral medicine
    • Injection or infusion

    Comparing the effects of the mechanical thrombectomy versus medical treatment alone on development and severity of post pulmonary embolism syndrome. To define predictors of post pulmonary embolism syndrome.

    Trial name
    PE/CBT (NCT07885787)
    Testing
    The Indigo aspiration system
    Where
    Egypt
    Volunteers
    120 people
    Sponsor
    Assiut University
    Can I take part? PE/CBT
  • Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension

    Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance

    • Recruiting
    • Age: 18 years and older
    • Observational study

    PERSEUS is an academic, investigator-initiated, multicenter observational registry of adults with acute pulmonary embolism (PE), promoted by Azienda Ospedaliero-Universitaria Careggi (Florence, Italy).

    Conditions
    Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension, Right Ventricular Dysfunction, Pulmonary Embolism (PE)
    Trial name
    PERSEUS (NCT07855679)
    Testing
    Routine clinical care (no study intervention)
    Where
    16 sites in Italy, Poland and 1 more
    Volunteers
    5,000 people
    Sponsor
    Azienda Ospedaliero-Universitaria Careggi
    Can I take part? PERSEUS
  • Atrial Fibrillation (AF)

    Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

    • Recruiting
    • Age: 18 years and older
    • Phase 3

    This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly.

    Trial name
    ROXI-INCLINE (NCT07430956)
    Testing
    REGN7508, REGN9933
    Where
    44 sites in United States, Canada
    Volunteers
    2,628 people
    Sponsor
    Regeneron Pharmaceuticals
  • Cancer-Associated Thrombosis (CAT)

    REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

    • Recruiting
    • Age: 18 years and older
    • Phase 3

    This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CAT) in participants.

    Trial name
    ROXI-CAT-I (NCT07410117)
    Testing
    REGN7508
    Where
    23 sites in United States, Georgia and 1 more
    Volunteers
    1,120 people
    Sponsor
    Regeneron Pharmaceuticals
    Can I take part? ROXI-CAT-I
  • Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute

    Repeated Examinations for Typing Pulmonary Embolism

    • Recruiting
    • Age: 18 years and older
    • Observational study

    PURPOSE The two related purposes of the RE-TyPE study are: 1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2.

    Conditions
    Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute, Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism With Right Ventricle Enlargement
    Trial name
    RE-TyPE (NCT07491094)
    Where
    3 sites in Sweden
    Volunteers
    400 people
    Sponsor
    Sahlgrenska University Hospital
    Can I take part? RE-TyPE
  • Atrial Fibrillation (AF), Pulmonary Embolism (PE)

    Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study

    • Not yet recruiting
    • Age: 18 years and older
    • Injection or infusion
    • Medical device

    This study aims to investigate whether a quick, additional CT scan of the heart, performed immediately after a standard CT scan for pulmonary embolism, can effectively detect blood clots in the left atrial appendage (LAA) in…

    Conditions
    Atrial Fibrillation (AF), Pulmonary Embolism (PE), Left Atrial Appendage Thrombosis
    Trial name
    ELATE-AF (NCT07647939)
    Testing
    Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus, Delayed Gated CT Scan for Left Atrial Appendage Thrombus
    Where
    United States
    Volunteers
    60 people
    Sponsor
    Northwell Health
    Can I take part? ELATE-AF
  • Acute Pulmonary Embolism

    Comparing Three Catheter Aspiration Strategies for Intermediate-High-Risk Acute Pulmonary Embolism

    • Not yet recruiting
    • Age: 18 to 80 years
    • Medical device

    Acute pulmonary embolism (PE) is a serious and potentially life-threatening condition in which blood clots block the arteries of the lungs.

    Trial name
    NCT07869875
    Testing
    Small-bore (8-12 F) percutaneous catheter aspiration, Large-bore (16 F or larger) percutaneous catheter aspiration thrombectomy, Combined large-bore and small-bore percutaneous catheter aspiration
    Volunteers
    225 people, healthy volunteers welcome
    Sponsor
    Qiu Jipeng
    Can I take part? NCT07869875

Completed, with results posted

All –
  • Pulmonary Embolism Acute

    Comparison of Two Pulmonary Embolism Treatments

    • Completed
    • Age: 18 to 80 years
    • Medical device
    • Results posted

    The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment…

    Trial name
    NCT05684796
    Testing
    Anticoagulation, mechanical aspiration thrombectomy
    Where
    22 sites in United States, Canada and 2 more
    Volunteers
    100 people
    Sponsor
    Penumbra Inc.
    Can I take part? NCT05684796
  • Acute Pulmonary Embolism, Thromboembolism

    SYMPHONY-PE Study for Treatment of Pulmonary Embolism

    • Completed
    • Age: 18 to 80 years
    • Medical device
    • Results posted

    Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

    Conditions
    Acute Pulmonary Embolism, Thromboembolism, Emboli, Pulmonary, Thrombosis
    Trial name
    NCT06062329
    Testing
    Symphony Thrombectomy System
    Where
    19 sites in United States
    Volunteers
    110 people
    Sponsor
    Imperative Care, Inc.
    Can I take part? NCT06062329
  • Deep Vein Thrombosis, Deep Vein Thrombosis, Pulmonary Embolus

    Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection

    • Completed
    • Age: 18 years and older
    • Medical device
    • Results posted

    The purpose of this study is to confirm the safety and efficacy of ThinkSono Guidance, a software data collection and communication tool designed to collect ultrasound data to help detect blood clots in veins.

    Trial name
    DVT GUARD (NCT06652568)
    Testing
    ThinkSono System
    Where
    5 sites in United States
    Volunteers
    634 people
    Sponsor
    ThinkSono, Ltd.
    Can I take part? DVT GUARD
  • Pulmonary Embolism

    Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I

    • Completed
    • Age: 18 to 79 years
    • Medical device
    • Results posted

    This study study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of pulmonary…

    Trial name
    SPIRARE I (NCT06571760)
    Testing
    Vertex Pulmonary Embolectomy System
    Where
    2 sites in Austria, Poland
    Volunteers
    10 people
    Sponsor
    Neptune Medical
    Can I take part? SPIRARE I
  • Pulmonary Embolism, Venous Thromboembolism

    Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

    • Completed
    • Age: All ages
    • Pill or oral medicine
    • Lifestyle or therapy programme
    • Results posted

    The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers.

    Conditions
    Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation
    Trial name
    NCT05351749
    Testing
    New-prescription Alert, New-prescription Alert with referral option, Existing-prescription notification to prescriber
    Where
    United States
    Volunteers
    306 people
    Sponsor
    University of Michigan
    Can I take part? NCT05351749

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in